Skip to main content
TERA SCIENCE Co.,LTD logo

TERA SCIENCE Co.,LTD — Investor Relations & Filings

Ticker · 073640 ISIN · KR7073640005 KO Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2026-03-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 073640

About TERA SCIENCE Co.,LTD

http://tera-science.com/en/

TERA SCIENCE Co., Ltd. is a diversified technology company that has evolved from its foundational business of manufacturing hydraulic fittings and high-pressure components. The company now focuses on high-growth sectors through several key divisions. Its Future Materials business, via subsidiary Tera Technos, develops and manufactures advanced materials for secondary batteries, specializing in high-capacity silicon-based (SiOx) cathodes for lithium-ion applications. In the biotechnology field, TERA SCIENCE is engaged in cancer immunotherapy and vaccine development through a strategic investment in Oncopep. The company also operates in the renewable energy sector, providing solar and wind power solutions, and is expanding into environmental waste management technologies. The original parts and materials division continues to supply precision components.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates, share issuance details, and third-party allocation specifics. This type of filing is a standard regulatory disclosure for capital changes in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2026-03-12 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Transfer Shares and Equity Securities of Another Corporation' (타법인 주식 및 출자증권 양도결정). It is a regulatory filing submitted to the Financial Services Commission and the Korea Exchange, detailing the specifics of a share transfer, including payment schedules, external evaluation results, and counterparty information. This falls under the category of M&A activity or significant corporate transactions, which is best classified as 'TAR' (M&A Activity) within the provided schema.
2026-02-26 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 95% confidence The document is a regulatory filing from the Korean DART system regarding a 'Decision to Dispose of Shares and Securities of Another Corporation' (타법인주식및출자증권처분결정). It is a correction filing (정정신고) updating the expected disposal date. Since this relates to a corporate transaction involving the disposal of assets/shares, it falls under the category of general regulatory announcements that do not fit into specific categories like M&A or share buybacks, thus it is classified as a Regulatory Filing (RNS).
2026-02-26 Korean
[기재정정]타법인주식및출자증권처분결정(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a previous disclosure about the disposal of shares in another corporation (타법인주식및출자증권처분결정). It details the change in the expected disposal date. Since this is a specific regulatory disclosure regarding corporate capital/asset management and does not fit into the other specialized categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2026-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Tera Science) announcing a significant change (over 30%) in revenue or profit structure. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for listed companies to report material financial changes before the final audit is completed. It provides key financial highlights and reasons for the variance, fitting the definition of a regulatory filing for material financial events.
2026-02-23 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) for Tera Science Co., Ltd. It details the amendment of payment dates, share issuance details, and third-party allocation information. This type of filing is a standard regulatory disclosure for capital changes in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2026-02-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.